Matteo Villian, Veranova’s VP of peptides and Oligonucleotides, joined Leonardo Costa Siqueira from Novo Nordisk to discuss high volume GLP-1 manufacturing with Katie Anderson from Pharmaceutical Online.
Matteo and Leonardo focus on the analytical strategies required to enable high-volume production, including the deployment of high-throughput chromatographic methods for impurity profiling, integration of orthogonal techniques such as LC-MS for identity confirmation, and the role of stability-indicating methods in maintaining product quality. They also examine bottlenecks in traditional quality control, particularly the impact of assay turnaround times and bioassay variability on batch release.
Watch the Webinar on Pharmaceutical Online
